RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ALABISO O
Collezione AOU San Luigi di Orbassano

Items : 5

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. in International journal of clinical oncology / Int J Clin Oncol. 2018 Apr;23(2):281-286. doi: 10.1007/s10147-017-1195-x. Epub 2017 Sep 27.

2018
AOU San Luigi di Orbassano

Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV; Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV;

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.

2012
AOU San Luigi di Orbassano

Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network. in BMC cancer / BMC Cancer. 2009 Nov 3;9:388. doi: 10.1186/1471-2407-9-388.

2009
AOU San Luigi di Orbassano

Brizzi MP; Berruti A; Ferrero A; Milanesi E; Volante M; Castiglione F; Birocco N; Bombaci S; Perroni D; Ferretti B; Alabiso O; Ciuffreda L; Bertetto O; Papotti M; Dogliotti L;

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.

2006
AOU San Luigi di Orbassano

Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.

2006
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;